StockmanThey don't seem to be up to much when it comes to getting revenue for shareholders.Spending shareholders funds is another matter. The October 2010 annual report of M2M shows that two directors consumed $396,026 as salary and fees.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025